(Total Views: 478)
Posted On: 08/13/2019 8:40:28 AM
Post# of 86052
Re: breezerunner #12002
EuroMed Therapeutics is building the ninth Israeli licensed producer to capitalize on the domestic medical marijuana market and Europe’s nascent export market — worth upwards of $66 billion .
- Israeli Licensed Producer: EuroMed is building Israel’s ninth licensed producer, compared to more than 160 LPs across Canada.
- Low Cost Production: Israel has an ideal climate for year round outdoor cannabis production — significantly lowering costs.
- European End Markets: Israel’s strategic location makes it ideal for exporting to Europe, where consumers pay $18+ per gram.
- Access to Talent: Israel is a global leader in cannabis research, as well as a biotech and pharmaceutical hub.
https://euromedtherapeutics.com/
$$$$UNVC$$$$
- Israeli Licensed Producer: EuroMed is building Israel’s ninth licensed producer, compared to more than 160 LPs across Canada.
- Low Cost Production: Israel has an ideal climate for year round outdoor cannabis production — significantly lowering costs.
- European End Markets: Israel’s strategic location makes it ideal for exporting to Europe, where consumers pay $18+ per gram.
- Access to Talent: Israel is a global leader in cannabis research, as well as a biotech and pharmaceutical hub.
https://euromedtherapeutics.com/
$$$$UNVC$$$$
(3)
(0)
"An investment in knowledge pays the best interest."
Benjamin Franklin
All posts are my opinion only.
Benjamin Franklin
All posts are my opinion only.
Scroll down for more posts ▼
